Physician profile
Jonathan A Kost
NPI 1346274792
$9,689.67
in general payments reported to CMS, 2019-2025
54 companies · $997 in 2025
The $997 reported for 2025 was more than what a typical Interventional Pain Medicine provider received nationally (typical 2025 total: $676).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,278 · 2020: $566 · 2021: $967 · 2022: $1,351 · 2023: $2,120 · 2024: $1,411 · 2025: $997.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,528.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,528.03 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $1,413.81 | 2019-2024 | Wavewriter Alpha Prime 16 |
| Abbvie INC. | $1,282.49 | 2021-2025 | |
| Spr Therapeutics, INC | $997.76 | 2019-2025 | Sprint Pns System |
| Scilex Pharmaceuticals INC. | $561.35 | 2019-2025 | Ztlido |
| Abbott Laboratories | $467.90 | 2019-2022 | |
| Ipsen Biopharmaceuticals, INC | $401.53 | 2019-2025 | Dysport |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $397.84 | 2019-2025 | Relistor |
| Allergan, INC. | $312.45 | 2019-2022 | |
| Medtronic, INC. | $309.19 | 2023-2024 | Intellis Adaptivestim |
| Pfizer INC. | $308.56 | 2019-2024 | |
| Bioventus LLC | $201.58 | 2019-2022 | |
| Amgen INC. | $197.07 | 2019-2020 | |
| Ibsa Pharma INC. | $185.83 | 2023-2025 | Licart, Tirosint, Tirosint |
| Biodelivery Sciences International, INC. | $178.51 | 2019-2020 | |
| Collegium Pharmaceutical, INC. | $155.07 | 2019-2025 | Belbuca, Xtampza |
Show all 54 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jonathan Kost listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.